As of May 29, 2025, Theralase Technologies Inc (TLT.V) reports a Current Ratio of 1.61.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Theralase Technologies Inc's Current Ratio
Over recent years, Theralase Technologies Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 1.61 |
| 2023-12-31 | 1.39 |
| 2022-12-31 | 3.67 |
| 2021-12-31 | 5.71 |
| 2020-12-31 | 10.85 |
This slight downward trend highlights how Theralase Technologies Inc manages its short-term assets and liabilities over time.
Comparing Theralase Technologies Inc's Current Ratio to Peers
To better understand Theralase Technologies Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Theralase Technologies Inc (TLT.V) | 1.61 |
| Vivos Inc (RDGL) | 25.91 |
| Stock Trend Capital Inc (PUMP.CN) | 16.17 |
| Integrity Applications Inc (IGAP) | 7.61 |
| InVivo Therapeutics Holdings Corp (NVIV) | 7.13 |
| Viveve Medical Inc (VIVE) | 4.91 |
Compared to its competitors, Theralase Technologies Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.